
The Blood Test Revolution Driving These Three Stocks
A looming revolution in oncology could help the 18 million cancer survivors in the U.S. and bolster biotech stocks like Guardant Health (GH), Natera (NTRA) and Exact Sciences (EXAS). And all it takes is a little blood. ↑ X NOW PLAYING The Cell Therapy …